In Phase A, members will receive various doses and schedules of oral ABBV-744 pill to establish Secure dosing program. More individuals will likely be enrolled in the discovered monotherapy dosign program. In Segment B, contributors will obtain oral ruxolitinib and ABBV-744 will likely be offered as